Skin of Color
Neal Bhatia, MD, FAAD
Biologics and new JAK inhibitors play an important role in managing psoriasis. Neal Bhatia, MD offers his thoughts on when and why these treatments should be considered.
Arcutis Biotherapeutics Plans to Initiate Phase 3 Program for ARQ-151 for Plaque Psoriasis
UCB Presents New Data for Cimzia, Investigational Bimekizumab